Date published: 2026-5-16

1-800-457-3801

SCBT Portrait Logo
Seach Input

OR8G2 Inhibitors

OR8G2, a member of the olfactory receptor family of genes, plays a vital role in the detection of odorants in the olfactory system of organisms. This gene encodes a protein that is part of the G-protein coupled receptor (GPCR) superfamily, which is essential for olfactory signal transduction. The expression of OR8G2, like other genes, is subject to sophisticated regulatory mechanisms that ensure the appropriate cellular and temporal production of its protein product. The regulation of gene expression is a highly orchestrated process involving multiple levels of control, including epigenetic modifications, transcription factor binding, mRNA stability, and translational control. Understanding the intricate controls of OR8G2 expression is crucial for elucidating the complex nature of olfactory perception and the specificity of odorant detection. A selection of chemical compounds has been identified that could potentially inhibit the expression of the OR8G2 protein. These compounds operate through various mechanisms to decrease the production or availability of the OR8G2 protein. For instance, histone deacetylase inhibitors like Trichostatin A can alter chromatin structure, potentially leading to the downregulation of OR8G2 transcription. DNA intercalating agents and transcriptional inhibitors, such as Actinomycin D, directly block the transcriptional machinery, thereby reducing OR8G2 mRNA levels. Translation inhibitors like Cycloheximide can prevent the synthesis of OR8G2 protein by stalling mRNA translation. In addition, certain small-molecule inhibitors can indirectly lead to decreased expression of OR8G2 by targeting intracellular signaling pathways. Examples include PD98059, which inhibits the MEK1/ERK pathway, and LY294002, which acts on the PI3K/Akt pathway, both of which are involved in the control of gene expression. The use of these compounds provides valuable tools to dissect the regulatory networks that control OR8G2 expression and to enhance our understanding of the genetic control of olfactory systems.

Items 11 to 12 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Resveratrol

501-36-0sc-200808
sc-200808A
sc-200808B
100 mg
500 mg
5 g
$80.00
$220.00
$460.00
64
(2)

Resveratrol has the ability to downregulate the expression of certain genes through inhibition of transcription factor binding or alteration of the epigenetic state of gene promoters, which could include the OR8G2 gene.

Hydroxyurea

127-07-1sc-29061
sc-29061A
5 g
25 g
$78.00
$260.00
18
(1)

Hydroxyurea inhibits ribonucleotide reductase, leading to a depletion of deoxyribonucleotide triphosphates and a subsequent decrease in DNA synthesis; this could restrict the replication-dependent component of OR8G2 gene expression.